Expression of invasion-associated markers and pathways (AKT, PI3 kinase, STAT1), identified in our in vitro models, will be further investigated in clinical tumor samples, with a focus on high grade, metastasizing and invasive cancers. The gene discussed is AKT1; the disease is cancer.